{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:55:05Z","timestamp":1791950105195,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41397-020-0160-7","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:04:37Z","timestamp":1581033877000},"page":"717-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A methylation functional detection hepatic cell system validates correlation between DNA methylation and drug-induced liver injury"],"prefix":"10.1038","volume":"20","author":[{"given":"Yuqi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-3179","authenticated-orcid":false,"given":"Cong","family":"Huai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-5960","authenticated-orcid":false,"given":"Shengying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"160_CR1","doi-asserted-by":"publisher","first-page":"876","DOI":"10.5858\/arpa.2014-0214-RA","volume":"139","author":"K Fisher","year":"2015","unstructured":"Fisher K, Vuppalanchi R, Saxena R. Drug-induced liver injury. Arch Pathol Lab Med. 2015;139:876\u201387.","journal-title":"Arch Pathol Lab Med"},{"key":"160_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.29152","volume":"66","author":"CM Hunt","year":"2017","unstructured":"Hunt CM, Papay JI, Stanulovic V, Regev A. Drug rechallenge following drug-induced liver injury. Hepatology. 2017;66:646\u201354.","journal-title":"Hepatology"},{"key":"160_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/MOP.0000000000000264","volume":"27","author":"MD Amin","year":"2015","unstructured":"Amin MD, Harpavat S, Leung DH. Drug-induced liver injury in children. Curr Opin Pediatr. 2015;27:625\u201333.","journal-title":"Curr Opin Pediatr"},{"key":"160_CR4","unstructured":"Chen C. Research advances in drug-induced liver injury and existing problems in China. J Clini Hepatol. 2018;34:1147\u201351."},{"key":"160_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10565-016-9316-2","volume":"32","author":"Y Wu","year":"2016","unstructured":"Wu Y, Geng XC, Wang JF, Miao YF, Lu YL, Li B. The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury. Cell Biol Toxicol. 2016;32:37\u201359.","journal-title":"Cell Biol Toxicol"},{"key":"160_CR6","doi-asserted-by":"publisher","first-page":"s104","DOI":"10.7861\/clinmedicine.16-6-s104","volume":"16","author":"D Katarey","year":"2016","unstructured":"Katarey D, Verma S. Drug-induced liver injury. Clin Med. 2016;16:s104\u20139.","journal-title":"Clin Med"},{"key":"160_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/tx500504n","volume":"28","author":"JM Choi","year":"2015","unstructured":"Choi JM, Oh SJ, Lee JY, Jeon JS, Ryu CS, Kim YM, et al. Prediction of drug-induced liver injury in HepG2 cells cultured with human liver microsomes. Chem Res Toxicol. 2015;28:872\u201385.","journal-title":"Chem Res Toxicol"},{"key":"160_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/jcpt.12211","volume":"40","author":"R Chen","year":"2015","unstructured":"Chen R, Zhang Y, Tang S, Lv X, Wu S, Sun F, et al. The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-control Study. J Clin Pharm Ther. 2015;40:110\u20135.","journal-title":"J Clin Pharm Ther"},{"key":"160_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0034-1375954","volume":"34","author":"TJ Urban","year":"2014","unstructured":"Urban TJ, Daly AK, Aithal GP. Genetic basis of drug-induced liver injury: present and future. Semin Liver Dis. 2014;34:123\u201333.","journal-title":"Semin Liver Dis"},{"key":"160_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrg3354","volume":"14","author":"ZD Smith","year":"2013","unstructured":"Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013;14:204\u201320.","journal-title":"Nat Rev Genet"},{"key":"160_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg1655","volume":"6","author":"KD Robertson","year":"2005","unstructured":"Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6:597\u2013610.","journal-title":"Nat Rev Genet"},{"key":"160_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11:726\u201334.","journal-title":"Nat Rev Cancer"},{"key":"160_CR13","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2741\/4508","volume":"22","author":"K Meier","year":"2017","unstructured":"Meier K, Recillas-Targa F. New insights on the role of DNA methylation from a global view. Front Biosci. 2017;22:644\u201368.","journal-title":"Front Biosci"},{"key":"160_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","volume":"146","author":"RJ Fontana","year":"2014","unstructured":"Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914\u201328.","journal-title":"Gastroenterology"},{"key":"160_CR15","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhu X, Li Y, Zhu L, Li S, Zheng G, et al. Correlation of CpG island methylation of the cytochrome P450 2E1\/2D6 genes with liver injury induced by anti-tuberculosis drugs: a nested Case-control Study. Int J Environ Res Public Health. 2016;13:E776.","DOI":"10.3390\/ijerph13080776"},{"key":"160_CR16","doi-asserted-by":"crossref","unstructured":"Gunness\u00a0P, Mueller D, Shevchenko V, Heinzle E, Ingelman-Sundberg M, Noor F. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicol Sci. 2013;133:67\u201378.","DOI":"10.1093\/toxsci\/kft021"},{"key":"160_CR17","doi-asserted-by":"crossref","unstructured":"Tomida T, Okamura H, Satsukawa M, Yokoi T, Konno Y. Multiparametric assay using HepaRG cells for predicting drug-induced liver injury. Toxicol Lett. 2015;236:16\u201324.","DOI":"10.1016\/j.toxlet.2015.04.014"},{"key":"160_CR18","doi-asserted-by":"crossref","unstructured":"Antherieu S, Chesne C, Li R, Guguen-Guillouzo C, Guillouzo A. Optimization of the HepaRG cell model for drug metabolism and toxicity studies. Toxicol Vitr. 2012;26:1278\u201385.","DOI":"10.1016\/j.tiv.2012.05.008"},{"key":"160_CR19","doi-asserted-by":"crossref","unstructured":"Aninat C, Piton A, Glaise D, Le Charpentier T, Langouet S, Morel F, et al. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos. 2006;34:75\u201383.","DOI":"10.1124\/dmd.105.006759"},{"key":"160_CR20","doi-asserted-by":"crossref","unstructured":"McDonald JI, Celik H, Rois LE, Fishberger G, Fowler T, Rees R, et al. Reprogrammable CRISPR\/Cas9-based system for inducing site-specific DNA methylation. Biol Open. 2016;5:866\u201374.","DOI":"10.1242\/bio.019067"},{"key":"160_CR21","doi-asserted-by":"crossref","unstructured":"He L, Gao L, Shi Z, Li Y, Zhu L, Li S, et.al. Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case\u2013Control Study. PLOS ONE. 2015;10:e0119481.","DOI":"10.1371\/journal.pone.0119481"},{"key":"160_CR22","doi-asserted-by":"crossref","unstructured":"Li Y, Ren Q, Zhu L, Li Y, Li J, Zhang Y, et al. Involvement of methylation of MicroRNA-122, -125b and -106b in regulation of Cyclin G1, CAT-1 and STAT3 target genes in isoniazid-induced liver injury. Bmc Pharmacol Toxicol. 2018;19:11.","DOI":"10.1186\/s40360-018-0201-x"},{"key":"160_CR23","unstructured":"Li Y, Li Y, Zheng G, Zhu L, Wang J, Mu S, et al. Cytochrome P450 1A1 and 1B1 promoter CpG island methylation regulates rat liver injury induced by isoniazid. Mol Med Rep. 2018;17:753\u201362."},{"key":"160_CR24","doi-asserted-by":"crossref","unstructured":"GoMez-LechoN MJ, Tolosa L, Castell JV, Donato MT. Mechanism-based selection of compounds for the development of innovative in vitro approaches to hepatotoxicity studies in the LIINTOP project. Toxicol Vitr. 2010;24:1879\u201389.","DOI":"10.1016\/j.tiv.2010.07.018"},{"key":"160_CR25","doi-asserted-by":"crossref","unstructured":"Howell LS, Ireland L, Park BK, Goldring CE. MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury. Expert Rev Mol Diagn. 2018;18:47\u201354.","DOI":"10.1080\/14737159.2018.1415145"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41397-020-0160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-020-0160-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41397-020-0160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:00:28Z","timestamp":1684616428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-0160-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1038\/s41397-020-0160-7","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"assertion":[{"value":"29 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}